Business
SOPHiA GENETICS Reports First Quarter 2025 Results
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2025.
About this update from Sophia Genetics Sa
[{"type":"text","content":"BOSTON and ROLLE, Switzerland, May 6, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2025.","length":235,"tagName":"p"},{"type":"image","alt":"SOPHiA GENETICS Logo (PRNewsfoto/SOPHiA GENETICS)","displaySize":"","headline":null,"caption":"SOPHiA GENETICS Logo (PRNewsfoto/SOPHiA GENETICS)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/7af8bf13f8f939ef861dc0027929881b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/n6kFaeXBXi.jQBj8QTEY9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7af8bf13f8f939ef861dc0027929881b","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/1673202/SOPHiA_GENETICS_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"First Quarter 2025 Financial Results","length":41,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $17.8 million, up 13% year-over-year or 15% on a constant currency basis","length":84,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross margin was 68.7% on a reported basis and 75.7% on an adjusted basis, up from 65.9% and 70.5% in the prior year period, respectively","length":137,"tagName":"p"}]},{"val":[{"type":"text","content":"IFRS net loss increased 27% year-over-year to $17.4 million (including a net foreign exchange P&L impact of $5.2 million), and adjusted EBITDA loss improved 24% year-over-year to $9.8 million","length":195,"tagName":"p"}]},{"val":[{"type":"text","content":"The company reiterates full-year guidance of revenue between $72 million and $76 million and adjusted EBITDA loss between $35 million and $39 million","length":149,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":565,"olType":false},{"type":"text","content":""We started the year strong with year-over-year revenue growth of 13%, or 15% on a constant currency basis, as the large amount of new business signed in 2024 begins to ramp," said Jurgi Camblong, PhD., Chief Executive Officer and Co-founder. "In addition to reaccelerating topline growth, we also continued to optimize SOPHiA DDM™'s data processing capabilities ...